Company News

Forus Health announces launch of affordable 3nethra NEO – An effective Made in India tool to address childhood blindness

Views: 2.9K
K Chandrasekhar, Founder & CEO, Forus Health

K Chandrasekhar, Founder & CEO, Forus Health underlined that 3nethra NEO is a result of consistent efforts & clinical trials

Forus Health Private Limited, a Bengaluru-based medical devices company focused on developing state-of-the-art ophthalmic devices, has announced the launch of 3nethra NEO, which is a Retinopathy of Prematurity (ROP) imaging platform.

Forus Health – Overview  

Founded in 2010, Forus Health aims to eradicate preventable blindness using technology. It has successfully deployed thousands of its flagship adult retinal imaging device – 3nethra classic in 25 countries.

Dr Shyam Vasudeva Rao ,Founder & Director Forus Health along with K Chandrasekhar highlighted the key features of 3nethra NEO

Dr Shyam Vasudeva Rao ,Founder & Director Forus Health along with K Chandrasekhar highlighted the key features of 3nethra NEO

Understanding Retinopathy of Prematurity (ROP)

  • The leading cause of blindness in infants in the world.
  • In India, one out of three babies born less than 2,000 grams develops the disease and 10 percent of the babies will turn blind at the age of 2 months if not treated on time.
  • Annually, over 3.5 million babies are born premature in India.
  • Less than 100 ROP specialists nationwide to screen & treat this condition.
3nethra neo is the most affordable ROP imaging device with an integrated telemedicine platform that helps in remote diagnosis

3nethra neo is the most affordable ROP imaging device with an integrated telemedicine platform that helps in remote diagnosis

3nethra NEO – Key Takeaways

  • Result of consistent efforts to build affordable & state-of-the-art imaging solutions for eye care.
  • One of solutions of collaboration with Narayana Nethralaya for clinical trials.
  • Most affordable ROP imaging device with an integrated telemedicine platform that helps in remote diagnosis.
  • The device costs one fourth of its nearest competitor.
  • Quality was found to be at par with the imported cameras during clinical trials.
  • Found to be useful for telemedicine settings during clinical trials under Narayana Nethralaya’s KIDROP outreach programme

3nethra NEO – Key Features

  • Has four design patents for this product to protect design.
  • A light weight & compact wide-angle imaging device.
  • Its skillfully designed optics, ergonomic natural grip for easy holding & high reliability enhanced by a unique focusing and illumination system makes it an ideal choice for neonatal ICUs.

Understanding  the Karnataka Internet Assisted Diagnosis of Retinopathy of Prematurity (KIDROP) Programme

  • In 2007, Narayana Nethralaya pioneered an ROP screening programme called KIDROP.
  • Screens premature infants in rural areas & detects and treats this condition using a unique telemedicine model.
  • It is currently the world’s largest tele-ROP programme that serves over 102 rural units.
  • Cited by the United Nations Development Programme (UNDP), Niti Ayog or the National Institution for Transforming India, Harvard Business Review, IIM-A, IIM-B and been validated by the CDC Atlanta guidelines.
  • In June 2016, KIDROP was awarded the National Award for HealthCare Excellence for Rural Outreach.

Most Popular

 

 


 

 

Get Heard Portal

 

eHealth Event Report

 

 

To Top